Indicator type;Branch of activity;Total Number of companies carrying out R&D in Biotechnology;Total companies;1,376 Number of companies carrying out R&D in Biotechnology;Agriculture;98 Number of companies carrying out R&D in Biotechnology;Industry and Construction;407 Number of companies carrying out R&D in Biotechnology;Services;871 % Companies by type of biotechnology used: Genetic Code;Total companies;31.4 % Companies by type of biotechnology used: Genetic Code;Agriculture;19.4 % Companies by type of biotechnology used: Genetic Code;Industry and Construction;17.2 % Companies by type of biotechnology used: Genetic Code;Services;39.5 % Companies by type of biotechnology used: Functional Units;Total companies;43.7 % Companies by type of biotechnology used: Functional Units;Agriculture;28.8 % Companies by type of biotechnology used: Functional Units;Industry and Construction;40.3 % Companies by type of biotechnology used: Functional Units;Services;47.0 % Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Total companies;22.8 % Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Agriculture;14.6 % Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Industry and Construction;18.2 % Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Services;25.9 % Companies by type of biotechnology used: Bioprocesses;Total companies;48.3 % Companies by type of biotechnology used: Bioprocesses;Agriculture;40.3 % Companies by type of biotechnology used: Bioprocesses;Industry and Construction;74.5 % Companies by type of biotechnology used: Bioprocesses;Services;37.0 % Companies by type of biotechnology used: Subcellular Organisms;Total companies;7.9 % Companies by type of biotechnology used: Subcellular Organisms;Agriculture;5.0 % Companies by type of biotechnology used: Subcellular Organisms;Industry and Construction;4.9 % Companies by type of biotechnology used: Subcellular Organisms;Services;9.6 % Companies by type of biotechnology used: Bioinformatics;Total companies;27.1 % Companies by type of biotechnology used: Bioinformatics;Agriculture;11.9 % Companies by type of biotechnology used: Bioinformatics;Industry and Construction;13.0 % Companies by type of biotechnology used: Bioinformatics;Services;35.5 % Companies by type of biotechnology used: Nanobiotechnology;Total companies;11.2 % Companies by type of biotechnology used: Nanobiotechnology;Agriculture;1.1 % Companies by type of biotechnology used: Nanobiotechnology;Industry and Construction;7.2 % Companies by type of biotechnology used: Nanobiotechnology;Services;14.3 % Companies by type of biotechnology used: Other;Total companies;17.6 % Companies by type of biotechnology used: Other;Agriculture;30.3 % Companies by type of biotechnology used: Other;Industry and Construction;9.5 % Companies by type of biotechnology used: Other;Services;20.0 Companies in which biotechnology activities are: Main and/or exclusive;Total companies;711 Companies in which biotechnology activities are: Main and/or exclusive;Agriculture;22 Companies in which biotechnology activities are: Main and/or exclusive;Industry and Construction;112 Companies in which biotechnology activities are: Main and/or exclusive;Services;576 Companies in which biotechnology activities are: A secondary business line;Total companies;270 Companies in which biotechnology activities are: A secondary business line;Agriculture;22 Companies in which biotechnology activities are: A secondary business line;Industry and Construction;107 Companies in which biotechnology activities are: A secondary business line;Services;140 Companies in which biotechnology activities are: A necessary tool for production;Total companies;395 Companies in which biotechnology activities are: A necessary tool for production;Agriculture;53 Companies in which biotechnology activities are: A necessary tool for production;Industry and Construction;188 Companies in which biotechnology activities are: A necessary tool for production;Services;154 % Companies by final application areas of biotechnology use: Human Health;Total companies;48.0 % Companies by final application areas of biotechnology use: Human Health;Agriculture;1.2 % Companies by final application areas of biotechnology use: Human Health;Industry and Construction;25.1 % Companies by final application areas of biotechnology use: Human Health;Services;63.9 % Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Total companies;16.9 % Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Agriculture;27.6 % Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Industry and Construction;14.0 % Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Services;17.0 % Companies by final application areas of biotechnology use: Food Products;Total companies;29.4 % Companies by final application areas of biotechnology use: Food Products;Agriculture;26.9 % Companies by final application areas of biotechnology use: Food Products;Industry and Construction;48.0 % Companies by final application areas of biotechnology use: Food Products;Services;21.0 % Companies by final application areas of biotechnology use: Agriculture and Forestry;Total companies;25.7 % Companies by final application areas of biotechnology use: Agriculture and Forestry;Agriculture;69.5 % Companies by final application areas of biotechnology use: Agriculture and Forestry;Industry and Construction;25.4 % Companies by final application areas of biotechnology use: Agriculture and Forestry;Services;20.9 % Companies by final application areas of biotechnology use: Environment;Total companies;18.0 % Companies by final application areas of biotechnology use: Environment;Agriculture;12.4 % Companies by final application areas of biotechnology use: Environment;Industry and Construction;20.9 % Companies by final application areas of biotechnology use: Environment;Services;17.4 % Companies by final application areas of biotechnology use: Industry;Total companies;13.0 % Companies by final application areas of biotechnology use: Industry;Agriculture;5.5 % Companies by final application areas of biotechnology use: Industry;Industry and Construction;15.5 % Companies by final application areas of biotechnology use: Industry;Services;12.7 R&D personnel in Biotechnology (PP);Total companies;17,257 R&D personnel in Biotechnology (PP);Agriculture;1,029 R&D personnel in Biotechnology (PP);Industry and Construction;4,994 R&D personnel in Biotechnology (PP);Services;11,233 R&D personnel in Biotechnology (PP): Research personnel;Total companies;9,195 R&D personnel in Biotechnology (PP): Research personnel;Agriculture;265 R&D personnel in Biotechnology (PP): Research personnel;Industry and Construction;2,023 R&D personnel in Biotechnology (PP): Research personnel;Services;6,908 R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Total companies;8,061 R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Agriculture;764 R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Industry and Construction;2,972 R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Services;4,325 R&D personnel in Biotechnology (PP). Women;Total companies;9,980 R&D personnel in Biotechnology (PP). Women;Agriculture;441 R&D personnel in Biotechnology (PP). Women;Industry and Construction;2,831 R&D personnel in Biotechnology (PP). Women;Services;6,709 R&D personnel in Biotechnology (PP). Women: Research personnel;Total companies;5,222 R&D personnel in Biotechnology (PP). Women: Research personnel;Agriculture;109 R&D personnel in Biotechnology (PP). Women: Research personnel;Industry and Construction;1,139 R&D personnel in Biotechnology (PP). Women: Research personnel;Services;3,974 R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Total companies;4,758 R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Agriculture;332 R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Industry and Construction;1,691 R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Services;2,735 R&D personnel in Biotechnology (FTE);Total companies;12,883.4 R&D personnel in Biotechnology (FTE);Agriculture;700.0 R&D personnel in Biotechnology (FTE);Industry and Construction;3,623.0 R&D personnel in Biotechnology (FTE);Services;8,560.3 R&D personnel in Biotechnology (FTE): Research personnel;Total companies;7,103.2 R&D personnel in Biotechnology (FTE): Research personnel;Agriculture;191.6 R&D personnel in Biotechnology (FTE): Research personnel;Industry and Construction;1,552.1 R&D personnel in Biotechnology (FTE): Research personnel;Services;5,359.5 R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Total companies;5,780.2 R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Agriculture;508.5 R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Industry and Construction;2,070.9 R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Services;3,200.8 R&D personnel in Biotechnology (FTE). Women;Total companies;7,600.6 R&D personnel in Biotechnology (FTE). Women;Agriculture;304.9 R&D personnel in Biotechnology (FTE). Women;Industry and Construction;2,202.7 R&D personnel in Biotechnology (FTE). Women;Services;5,093.0 R&D personnel in Biotechnology (FTE). Women: Research personnel;Total companies;4,057.0 R&D personnel in Biotechnology (FTE). Women: Research personnel;Agriculture;85.2 R&D personnel in Biotechnology (FTE). Women: Research personnel;Industry and Construction;911.7 R&D personnel in Biotechnology (FTE). Women: Research personnel;Services;3,060.1 R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Total companies;3,543.7 R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Agriculture;219.7 R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Industry and Construction;1,291.0 R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Services;2,032.9 Expenditure on internal R&D in Biotechnology (thousands of euros);Total companies;1,283,346 Expenditure on internal R&D in Biotechnology (thousands of euros);Agriculture;47,651 Expenditure on internal R&D in Biotechnology (thousands of euros);Industry and Construction;392,948 Expenditure on internal R&D in Biotechnology (thousands of euros);Services;842,746 1) By type of expenditure: Current expenditure;Total companies;1,180,187 1) By type of expenditure: Current expenditure;Agriculture;43,927 1) By type of expenditure: Current expenditure;Industry and Construction;367,183 1) By type of expenditure: Current expenditure;Services;769,077 1.1) Labour expenditure of research personnel;Total companies;372,421 1.1) Labour expenditure of research personnel;Agriculture;9,505 1.1) Labour expenditure of research personnel;Industry and Construction;106,176 1.1) Labour expenditure of research personnel;Services;256,740 1.2) Labour expenditure of technical and auxiliary personnel;Total companies;229,734 1.2) Labour expenditure of technical and auxiliary personnel;Agriculture;18,692 1.2) Labour expenditure of technical and auxiliary personnel;Industry and Construction;87,860 1.2) Labour expenditure of technical and auxiliary personnel;Services;123,182 1.3) Other current expenditure;Total companies;578,032 1.3) Other current expenditure;Agriculture;15,730 1.3) Other current expenditure;Industry and Construction;173,147 1.3) Other current expenditure;Services;389,155 2) By type of expenditure: Capital expenditure;Total companies;103,159 2) By type of expenditure: Capital expenditure;Agriculture;3,725 2) By type of expenditure: Capital expenditure;Industry and Construction;25,766 2) By type of expenditure: Capital expenditure;Services;73,669 2.1) Land and buildings;Total companies;10,889 2.1) Land and buildings;Agriculture;500 2.1) Land and buildings;Industry and Construction;1,158 2.1) Land and buildings;Services;9,231 2.2) Equipment and tools;Total companies;59,204 2.2) Equipment and tools;Agriculture;3,152 2.2) Equipment and tools;Industry and Construction;17,922 2.2) Equipment and tools;Services;38,130 2.3) Acquisition of specific R&D software;Total companies;5,623 2.3) Acquisition of specific R&D software;Agriculture;5 2.3) Acquisition of specific R&D software;Industry and Construction;879 2.3) Acquisition of specific R&D software;Services;4,739 2.4) Other R&D-specific IP products;Total companies;27,442 2.4) Other R&D-specific IP products;Agriculture;67 2.4) Other R&D-specific IP products;Industry and Construction;5,807 2.4) Other R&D-specific IP products;Services;21,569 1.1) By origin of funds: Own funds;Total companies;887,527 1.1) By origin of funds: Own funds;Agriculture;45,510 1.1) By origin of funds: Own funds;Industry and Construction;325,418 1.1) By origin of funds: Own funds;Services;516,599 1.2) By origin of funds: Funds from the Business sector;Total companies;143,903 1.2) By origin of funds: Funds from the Business sector;Agriculture;280 1.2) By origin of funds: Funds from the Business sector;Industry and Construction;3,861 1.2) By origin of funds: Funds from the Business sector;Services;139,762 1.3) By origin of funds: Funds from the Public Administration sector;Total companies;126,546 1.3) By origin of funds: Funds from the Public Administration sector;Agriculture;1,841 1.3) By origin of funds: Funds from the Public Administration sector;Industry and Construction;15,631 1.3) By origin of funds: Funds from the Public Administration sector;Services;109,074 1.4) By origin of funds: Funds from the Higher Education sector;Total companies;94 1.4) By origin of funds: Funds from the Higher Education sector;Agriculture;0 1.4) By origin of funds: Funds from the Higher Education sector;Industry and Construction;0 1.4) By origin of funds: Funds from the Higher Education sector;Services;94 1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Total companies;12,623 1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Agriculture;0 1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Industry and Construction;47 1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Services;12,576 1.6) By origin of funds: Funds from the rest of the world;Total companies;112,652 1.6) By origin of funds: Funds from the rest of the world;Agriculture;21 1.6) By origin of funds: Funds from the rest of the world;Industry and Construction;47,991 1.6) By origin of funds: Funds from the rest of the world;Services;64,641 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Total companies;137,432 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Agriculture;703 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Industry and Construction;68,573 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Services;68,156 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Total companies;88,127 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Agriculture;631 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Industry and Construction;59,264 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Services;28,231 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Total companies;49,305 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Agriculture;72 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Industry and Construction;9,309 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Services;39,924 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Total companies;43.7 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Agriculture;36.5 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Industry and Construction;31.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Services;50.3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Total companies;16.2 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Agriculture;18.8 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Industry and Construction;17.3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Services;15.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Total companies;23.7 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Agriculture;27.2 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Industry and Construction;24.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Services;22.9 % Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Total companies;14.5 % Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Agriculture;13.2 % Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Industry and Construction;13.3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Services;15.1 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Total companies;18.1 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Agriculture;13.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Industry and Construction;9.7 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Services;22.5 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Total companies;19.6 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Agriculture;14.1 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Industry and Construction;12.5 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Services;23.5 % Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Total companies;19.1 % Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Agriculture;19.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Industry and Construction;18.8 % Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Services;19.3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Total companies;49.8 % Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Agriculture;45.6 % Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Industry and Construction;46.2 % Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Services;52.0 % Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Total companies;59.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Agriculture;49.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Industry and Construction;53.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Services;63.3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Total companies;22.3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Agriculture;19.4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Industry and Construction;18.9 % Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Services;24.2 % Companies with international revenues related to biotechnology activities;Total companies;23.6 % Companies with international revenues related to biotechnology activities;Agriculture;8.7 % Companies with international revenues related to biotechnology activities;Industry and Construction;21.1 % Companies with international revenues related to biotechnology activities;Services;26.4 % Companies representing international revenues related to biotechnology activities;Total companies;1.5 % Companies representing international revenues related to biotechnology activities;Agriculture;0.5 % Companies representing international revenues related to biotechnology activities;Industry and Construction;1.3 % Companies representing international revenues related to biotechnology activities;Services;2.7 % International revenues related to biotechnology activities distributed in: Revenues from the EU;Total companies;57.6 % International revenues related to biotechnology activities distributed in: Revenues from the EU;Agriculture;58.1 % International revenues related to biotechnology activities distributed in: Revenues from the EU;Industry and Construction;58.3 % International revenues related to biotechnology activities distributed in: Revenues from the EU;Services;54.9 % International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Total companies;42.4 % International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Agriculture;41.9 % International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Industry and Construction;41.7 % International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Services;45.1 % International revenues related to biotechnology activities by classification: International trade in goods and services;Total companies;82.3 % International revenues related to biotechnology activities by classification: International trade in goods and services;Agriculture;64.5 % International revenues related to biotechnology activities by classification: International trade in goods and services;Industry and Construction;83.1 % International revenues related to biotechnology activities by classification: International trade in goods and services;Services;79.9 % International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total companies;14.1 % International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Agriculture;35.0 % International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Industry and Construction;15.6 % International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Services;7.9 % International revenues related to biotechnology activities by classification: Subsidies from external sources;Total companies;1.5 % International revenues related to biotechnology activities by classification: Subsidies from external sources;Agriculture;0.0 % International revenues related to biotechnology activities by classification: Subsidies from external sources;Industry and Construction;0.0 % International revenues related to biotechnology activities by classification: Subsidies from external sources;Services;7.0 % International revenues related to biotechnology activities by classification: Other;Total companies;2.1 % International revenues related to biotechnology activities by classification: Other;Agriculture;0.5 % International revenues related to biotechnology activities by classification: Other;Industry and Construction;1.2 % International revenues related to biotechnology activities by classification: Other;Services;5.2